Harrow Health Inc
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, … Read more
Harrow Health Inc (HROW) - Total Liabilities
Latest total liabilities as of September 2025: $316.41 Million USD
Based on the latest financial reports, Harrow Health Inc (HROW) has total liabilities worth $316.41 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Harrow Health Inc - Total Liabilities Trend (2005–2024)
This chart illustrates how Harrow Health Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Harrow Health Inc Competitors by Total Liabilities
The table below lists competitors of Harrow Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Rémy Cointreau SA
PINK:REMYF
|
USA | $1.54 Billion |
|
Tikehau Capital
PINK:TKKHF
|
USA | $2.40 Billion |
|
Hyundai Construction Equipment Co Ltd
KO:267270
|
Korea | ₩1.66 Trillion |
|
Forehope Electronic (Ningbo) Co. Ltd. A
SHG:688362
|
China | CN¥10.33 Billion |
|
Boai NKY Pharmaceuticals Ltd
SHE:300109
|
China | CN¥552.11 Million |
|
Shandong Dongyue Organosilicon Mat
SHE:300821
|
China | CN¥1.18 Billion |
Liability Composition Analysis (2005–2024)
This chart breaks down Harrow Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.72 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 6.73 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.87 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Harrow Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Harrow Health Inc (2005–2024)
The table below shows the annual total liabilities of Harrow Health Inc from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $319.67 Million | +32.23% |
| 2023-12-31 | $241.75 Million | +85.77% |
| 2022-12-31 | $130.14 Million | +48.90% |
| 2021-12-31 | $87.40 Million | +185.19% |
| 2020-12-31 | $30.65 Million | -3.22% |
| 2019-12-31 | $31.67 Million | +28.21% |
| 2018-12-31 | $24.70 Million | +15.95% |
| 2017-12-31 | $21.30 Million | +2.34% |
| 2016-12-31 | $20.82 Million | +34.15% |
| 2015-12-31 | $15.52 Million | +641.66% |
| 2014-12-31 | $2.09 Million | +221.54% |
| 2013-12-31 | $650.63K | -8.31% |
| 2012-12-31 | $709.56K | -61.87% |
| 2011-12-31 | $1.86 Million | +33.83% |
| 2010-12-31 | $1.39 Million | +27.00% |
| 2009-12-31 | $1.09 Million | +43.31% |
| 2008-12-31 | $763.99K | +1.83% |
| 2007-12-31 | $750.24K | +19236.11% |
| 2006-12-31 | $3.88K | -21.62% |
| 2005-12-31 | $4.95K | -- |